IBX 0.00% 7.4¢ imagion biosystems limited

Magsense trialling, page-7

  1. 768 Posts.
    lightbulb Created with Sketch. 193

    Great thanks. Interesting we are working with Monash to develop the prostate cancer product but they’re also working on their own separate imaging instrument which seemingly is strikingly similar in its utility to our magsense. Hopefully we have protection with the prostate product.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.